METROPOLITAN LIFE INSURANCE CO/NY - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$37,638
+1.0%
4,127
+17.2%
0.00%0.0%
Q2 2023$37,252
-13.5%
3,5210.0%0.00%0.0%
Q1 2023$43,062
-16.4%
3,521
-15.2%
0.00%0.0%
Q4 2022$51,502
-9.1%
4,1500.0%0.00%
-33.3%
Q3 2022$56,689
-25.5%
4,1500.0%0.00%0.0%
Q2 2022$76,070
+14.0%
4,1500.0%0.00%
+50.0%
Q1 2022$66,732
-69.4%
4,150
-73.4%
0.00%
-33.3%
Q4 2021$218,316
-39.0%
15,594
-18.5%
0.00%
-40.0%
Q3 2021$358,174
-10.2%
19,1230.0%0.01%
-16.7%
Q2 2021$398,715
-22.6%
19,123
+5.0%
0.01%
-25.0%
Q1 2021$515,079
-16.2%
18,220
-3.2%
0.01%
-11.1%
Q4 2020$614,596
+20.5%
18,818
+13.0%
0.01%0.0%
Q3 2020$510,064
+88.0%
16,6470.0%0.01%
+80.0%
Q2 2020$271,346
+167.4%
16,647
+63.2%
0.01%
+150.0%
Q1 2020$101,490
-22.9%
10,200
+6.5%
0.00%0.0%
Q4 2019$131,643
-18.0%
9,574
-9.5%
0.00%
-33.3%
Q3 2019$160,559
-15.4%
10,584
+9.8%
0.00%0.0%
Q2 2019$189,772
+18.7%
9,6380.0%0.00%0.0%
Q1 2019$159,894
+18.2%
9,6380.0%0.00%0.0%
Q4 2018$135,318
-19.8%
9,6380.0%0.00%0.0%
Q3 2018$168,665
-99.9%
9,638
+26.3%
0.00%
+50.0%
Q2 2018$138,939,000
+3.7%
7,634
+6.9%
0.00%0.0%
Q1 2018$133,950,000
+122789.9%
7,1440.0%0.00%
+100.0%
Q4 2017$109,000
-50.0%
7,144
-51.0%
0.00%0.0%
Q3 2017$218,00014,5680.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders